文献速递造血干细胞移植与细胞治疗

狒狒包膜慢病毒载体高效转导人成人、胎儿及祖T细胞并纠正SCID-X1 T细胞缺陷

Baboon envelope LVs efficiently transduced human adult, fetal, and progenitor T cells and corrected SCID-X1 T-cell deficiency.
PubMed 文献 · Blood Adv · 2019-01-01

研究显示狒狒包膜糖蛋白假型慢病毒载体(BaEV-LVs)在转导经白细胞介素-7刺激的成人及胎儿初始T细胞方面远优于其他慢病毒假型,并能高效转导胸腺细胞及经Delta样配体4(Dll4)培养CD34+细胞生成的T细胞祖细胞。在NOD/SCIDγC-/-小鼠中,所有T细胞亚群维持80%-90%的高转导水平,且注射T细胞祖细胞较造血干细胞移植加速T细胞谱系重建。BaEV-LVs还能高效转导一例X连锁严重联合免疫缺陷(SCID-X1)患者的Dll4生成T细胞前体,并在体外完全挽救T细胞发育。

要点

  • BaEV-LVs转导经IL-7刺激的成人及胎儿初始T细胞的效果远优于其他慢病毒假型。
  • BaEV-LVs可高效转导胸腺细胞及Dll4培养CD34+细胞生成的T细胞祖细胞。
  • NOD/SCIDγC-/-小鼠中所有T细胞亚群维持80%-90%转导水平,T细胞祖细胞注射较造血干细胞移植加速T细胞重建。

核心结论

  • BaEV-LVs是遗传修饰初始T细胞的有价值工具,并可用于生成纠正基因的T细胞祖细胞,在体外挽救SCID-X1 T细胞发育。
  • 最终,慢病毒载体纠正的T细胞祖细胞与造血干细胞共注射可能加速免疫缺陷患者的T细胞重建。

研究设计与样本

  • 研究使用狒狒包膜糖蛋白假型慢病毒载体(BaEV-LVs)转导人成人及胎儿初始T细胞、胸腺细胞、经Dll4培养CD34+细胞生成的T细胞祖细胞及SCID-X1患者来源的T细胞前体,并在NOD/SCIDγC-/-小鼠中进行移植实验。

主要发现

  • BaEV-LVs转导经白细胞介素-7刺激的成人及胎儿初始T细胞的效果远优于其他慢病毒假型。
  • BaEV-LVs高效转导胸腺细胞及经Dll4培养CD34+细胞生成的T细胞祖细胞。
  • NOD/SCIDγC-/-小鼠移植后,所有T细胞亚群维持80%-90%的高转导水平。
  • NOD/SCIDγC-/-受体中,注射T细胞祖细胞较造血干细胞移植加速T细胞谱系重建。
  • γC编码的BaEV-LVs高效转导一例SCID-X1患者的Dll4生成T细胞前体,并在体外完全挽救T细胞发育。

关键数值与推荐

  • NOD/SCIDγC-/-小鼠移植后所有T细胞亚群维持80%-90%的转导水平。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

T cells represent a valuable tool for treating cancers and infectious and inherited diseases; however, they are mainly short-lived in vivo. T-cell therapies would strongly benefit from gene transfer into long-lived persisting naive T cells or T-cell progenitors. Here we demonstrate that baboon envelope glycoprotein pseudotyped lentiviral vectors (BaEV-LVs) far outperformed other LV pseudotypes for transduction of naive adult and fetal interleukin-7-stimulated T cells. Remarkably, BaEV-LVs efficiently transduced thymocytes and T-cell progenitors generated by culture of CD34+ cells on Delta-like ligand 4 (Dll4). Upon NOD/SCIDγC-/- engraftment, high transduction levels (80%-90%) were maintained in all T-cell subpopulations. Moreover, T-cell lineage reconstitution was accelerated in NOD/SCIDγC-/- recipients after T-cell progenitor injection compared with hematopoietic stem cell transplantation. Furthermore, γC-encoding BaEV-LVs very efficiently transduced Dll4-generated T-cell precursors from a patient with X-linked severe combined immunodeficiency (SCID-X1), which fully rescued T-cell development in vitro. These results indicate that BaEV-LVs are valuable tools for the genetic modification of naive T cells, which are important targets for gene therapy. Moreover, they allowed for the generation of gene-corrected T-cell progenitors that rescued SCID-X1 T-cell development in vitro. Ultimately, the coinjection of LV-corrected T-cell progenitors and hematopoietic stem cells might accelerate T-cell reconstitution in immunodeficient patients.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Bernadin O, Amirache F, Girard-Gagnepain A, et al. Baboon envelope LVs efficiently transduced human adult, fetal, and progenitor T cells and corrected SCID-X1 T-cell deficiency. Blood Adv. 2019. PMID: 30755435. doi:10.1182/bloodadvances.2018027508

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。